Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Motor Activity 4Stomach Neoplasms 3Rectal Neoplasms 3Neoplasms 3Pain, Postoperative 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Cognitive Complications 1Peritoneal Neoplasms 1Pediatric Brain Tumor 1Pathologic Processes 1Papillomavirus Infections 1Neuroendocrine Tumors 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Lymphedema 1Lymphatic Metastasis 1Liver Diseases 1Keratosis, Actinic 1Infections 1Gastrostomy 1Fatigue 1Epstein-Barr Virus Infections 1Endometrial Neoplasms 1Emergence Delirium 1

Interventions

remimazolam 1Sugammadex 1Pyridostigmine Bromide 1Propofol 1Injections 1Dexmedetomidine 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Emergence Delirium × Control Groups × Clear all
NCT07627906 2026-06-04

Ketofol Versus Ketodex for POD Prophylaxis in Elderly Cancer Surgery

Cairo University

Phase 3 Recruiting
180 enrolled

Emergence Delirium, Postoperative Cognitive Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡